Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
2026 Deceptive Ad Trends
A closer look at what we’ll be monitoring in the new year.
Why ‘Click-to-Cancel’ Still Matters – and Why the FTC Should Try Again
The problem hasn’t gone away.
Amazon’s Great Holiday Climb
Why parents may need to be called in to this Roblox game rated 13+.
Interior Icons’ 10-Year Warranty and 365-Day Returns
Taking advantage of these perks may be harder than advertised.
TINA.org’s Year in Review 2025
Looking back at our accomplishments